title: Between-subject variability in asymmetry analysis of macular thickness.
abstract: OBJECTIVE
  To investigate the use of asymmetry analysis to reduce between-subject variability of macular thickness measurements using spectral domain optical coherence tomography.
  
  
  METHODS
  Sixty-three volunteers (33 young subjects [aged 21 to 35 years] and 30 older subjects [aged 45 to 85 years]) free of eye disease were recruited. Macular images were gathered with the Spectralis optical coherence tomography. An overlay 24- by 24-degree grid was divided into five zones per hemifield, and asymmetry analysis was computed as the difference between superior and inferior zone thicknesses. We hypothesized that the lowest variation and the highest density of ganglion cells will be found approximately 3 to 6 degrees from the foveola, corresponding to zones 1 and 2. For each zone and age group, between-subject SDs were compared for retinal thickness versus asymmetry analysis using an F test. To account for repeated comparisons, p < 0.0125 was required for statistical significance. Axial length and corneal curvature were measured with an IOLMaster.
  
  
  RESULTS
  For OD, asymmetry analysis reduced between-subject variability in zones 1 and 2 in both groups (F > 3.2, p < 0.001). Standard deviation for zone 1 dropped from 12.0 to 3.0 μm in the young group and from 11.7 to 2.6 μm in the older group. Standard deviation for zone 2 dropped from 13.6 to 5.3 μm in the young group and from 11.1 to 5.8 μm in the older group. Combining all subjects, neither retinal thickness nor asymmetry analysis showed a strong correlation with axial length or corneal curvature (R² < 0.01). Analysis for OS yielded the same pattern of results, as did asymmetry analyses between eyes (F > 3.8, p < 0.0001).
  
  
  CONCLUSIONS
  Asymmetry analysis reduced between-subject variability in zones 1 and 2. Combining the five zones together produced a higher between-subject variation of the retinal thickness asymmetry analysis; thus, we encourage clinicians to be cautious when interpreting the asymmetry analysis printouts.
authors.affiliation: *MS †PhD, FAAO ‡OD, FAAO Indiana University School of Optometry, Bloomington, Indiana (all authors).
authors.forename: Muhammed S
authors.initials: MS
authors.lastname: Alluwimi
authors.forename: William H
authors.initials: WH
authors.lastname: Swanson
authors.forename: Victor E
authors.initials: VE
authors.lastname: Malinovsky
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D012160:Retina / Q000033:anatomy & histology*; D041623:Tomography, Optical Coherence / Q000379:methods*; D055815:Young Adult
references.citation: Eye (Lond). 2012 Dec;26(12):1563-70
references.pmid: 23079750
references.citation: Invest Ophthalmol Vis Sci. 2012 Aug 24;53(9):5788-98
references.pmid: 22836769
references.citation: Eye (Lond). 2008 Apr;22(4):551-5
references.pmid: 17464309
references.citation: Arch Ophthalmol. 2011 Dec;129(12):1529-36
references.pmid: 22159673
references.citation: Invest Ophthalmol Vis Sci. 2007 Jan;48(1):376-82
references.pmid: 17197557
references.citation: Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4437-43
references.pmid: 18539947
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):3913-8
references.pmid: 20357206
references.citation: Invest Ophthalmol Vis Sci. 2011 Oct 04;52(11):7872-9
references.pmid: 21873658
references.citation: Optom Vis Sci. 2012 May;89(5):620-31
references.pmid: 22525127
references.citation: Invest Ophthalmol Vis Sci. 2012 Mar 02;53(3):1139-44
references.pmid: 22247461
references.citation: Curr Eye Res. 2008 Aug;33(8):693-9
references.pmid: 18696345
references.citation: Ophthalmology. 1998 Feb;105(2):224-31
references.pmid: 9479279
references.citation: J Glaucoma. 2008 Oct-Nov;17(7):519-28
references.pmid: 18854727
references.citation: Arch Ophthalmol. 2009 Jul;127(7):875-81
references.pmid: 19597108
references.citation: Br J Ophthalmol. 2012 Jan;96(1):57-61
references.pmid: 21349942
references.citation: Invest Ophthalmol Vis Sci. 2011 Feb 01;52(1):625-34
references.pmid: 20861480
references.citation: Ophthalmology. 1999 Feb;106(2):269-73
references.pmid: 9951475
references.citation: Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4893-7
references.pmid: 18450592
references.citation: Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2889-95
references.pmid: 16799030
references.citation: Invest Ophthalmol Vis Sci. 2014 Jan 29;55(1):612-24
references.pmid: 24408977
references.citation: J Glaucoma. 2010 Mar;19(3):158-66
references.pmid: 19661824
references.citation: Invest Ophthalmol Vis Sci. 2011 Apr 16;52(5):2477-89
references.pmid: 21220552
references.citation: Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4886-92
references.pmid: 18539940
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4075-83
references.pmid: 20237247
references.citation: Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3653-61
references.pmid: 22562512
references.citation: Vision Res. 1983;23(6):581-7
references.pmid: 6612997
references.citation: Invest Ophthalmol Vis Sci. 2012 Aug 24;53(9):5853-9
references.pmid: 22836772
references.citation: Ophthalmology. 2003 Jan;110(1):177-89
references.pmid: 12511364
references.citation: Arch Ophthalmol. 2011 Sep;129(9):1205-11
references.pmid: 21911669
references.citation: Neurobiol Aging. 1996 May-Jun;17(3):377-84
references.pmid: 8725899
references.citation: Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8769-79
references.pmid: 21989721
references.citation: Invest Ophthalmol Vis Sci. 2011 Jun 06;52(7):3943-54
references.pmid: 21421869
references.citation: Science. 1983 Mar 25;219(4591):1441-4
references.pmid: 6828871
references.citation: J Comp Neurol. 1985 Aug 1;238(1):92-100
references.pmid: 4044906
references.citation: Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3515-23
references.pmid: 20164448
references.citation: Invest Ophthalmol Vis Sci. 2000 Mar;41(3):741-8
references.pmid: 10711689
references.citation: Arch Ophthalmol. 2004 Jun;122(6):827-37
references.pmid: 15197057
references.citation: J Glaucoma. 2005 Oct;14(5):358-63
references.pmid: 16148583
references.citation: Invest Ophthalmol Vis Sci. 2012 Jul 01;53(8):4347-53
references.pmid: 22577076
references.citation: Am J Ophthalmol. 2004 Jan;137(1):156-69
references.pmid: 14700659
references.citation: Invest Ophthalmol Vis Sci. 1992 May;33(6):2012-8
references.pmid: 1582806
references.citation: Arch Ophthalmol. 2003 Jan;121(1):41-6
references.pmid: 12523883
references.citation: Optom Vis Sci. 2012 Jan;89(1):4-11
references.pmid: 21983121
references.citation: J Comp Neurol. 1990 Oct 1;300(1):5-25
references.pmid: 2229487